Loss of skin volume and facial definition is a major sign of skin ageing but until now there were few skincare products that dealt specifically with this problem.

The challenge in developing Eucerin Volume-Filler was to identify potent, active ingredients that would target both the multiple causes of diminishing volume and improve facial contours, to give the face a more youthful appearance.

*In vitro tests

THE STORY BEHIND OUR NEW VOLUMISING RANGE

Skin looses volume due to a combination of natural and external factors which cause sagging, less-defined facial contours and may even start to affect facial expressions, as the distribution of volume-giving cells declines with age.

“It was a problem that, so far, hadn’t really been tackled with a topical skincare range,” explained Andrea Schölermann, MD, Clinical Advisor Eucerin. “But after intensive research of our consumers’ skin care needs as well as looking at the increasing number of mildly invasive volume-restoring procedures, we were inspired to work on a skin care formula that would reduce the signs of volume loss in ageing skin.”

“By combining three active ingredients into a powerful formula, we were able to develop a product range that went beyond the skin surface to work on the multiple factors responsible for the loss of natural volume.”

Eucerin scientists working in the laboratory
Our research focused on slowing the processes that lead to a loss of volume in the skin.
Working on the formulation of Eucerin Volume-Filler
The development of Eucerin Volume-Filler began with identifying Magnolol as the main active ingredient.
Magnolol causes increase in volume-giving cell

What are the active ingredients in Eucerin Hyaluron-Filler + Volume-Lift?

“Our starting point was an active, naturally-derived ingredient called Magnolol, extracted from the bark of the Magnolia tree. Magnolol stimulates volume-giving cells*, which are naturally located in the upper layers of skin. It also stimulates the production of messenger substances which increase the skin’s own collagen production.

We were also searching for an ingredient that could help to strengthen the skin structure.  As we age, and as cell regeneration and collagen production start to slow down, this naturally diminishes,” explained Andrea Schölermann.

We knew that if we could stop, or even partially reverse, this flattening we’d be able to bring back volume and strength to the skin.

 

Magnolol increases cell volume
Magnolol increases the number of volume giving cells (in vitro studies)

The peptides used in Eucerin Volume-Filler are extracted from the Anise fruit, traditionally grown for their beneficial healing qualities. “This specific type of naturally derived peptide has the ability to stimulate and support collagen production. It enhances skin’s metabolism, reactivates skin cell interactions and thus helps to strengthen the connective tissue,”* explained Schölermann.

The Eucerin Volume-Filler range contains three active ingredients – Magnolol, Oligo Peptides and Hyaluronic Acid.  The efficacy of the formula has been proven in multiple In vitro and In vivo studies conducted by Eucerin scientists.

One clinical and three dermatological studies have also been conducted to test the efficacy and tolerability of Eucerin Volume-Filler Concentrate on women between the ages of 40 and 75. In one study, 186 female volunteers, aged between 40 and 59, took part in a two-week trial where they used the product daily in combination with a volumising anti-ageing day care. The  self-assessments show that:

  • Volume is restored: 93% noted enhanced skin volume after regular use of Eucerin Volume-Filler Concentrate. 91% commented on their facial contours being redefined.
  • Skin is firmer: 98% saw a marked improvement in the firmness of their skin.
  • Skin looks younger: 95% indicated a reduction in the visible signs of ageing and 84% said that fine lines and wrinkles were visibly reduced.
  • Eucerin Volume-Filler Concentrate has good skin tolerability for all skin types:  99% found the product to be compatible with their skin.

*In vitro studies

186 female volunteers, aged between 40 and 59, took part in a two-week trial.